McClintock and Amfora Form Strategic Collaboration to Leverage AI to Improve Protein Content of Soy
SAN FRANCISCO, July 11, 2023 (GLOBE NEWSWIRE) — Artificial intelligence and machine learning innovator McClintock…
News
Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria
HAMPTON, N.J., July 11, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that…
Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria
HAMPTON, N.J., July 11, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that…
Akari Therapeutics Provides Update on Development of Long-Acting PAS-Nomacopan for Treatment of Geographic Atrophy
Akari has completed evaluation of long-acting PAS-nomacopan candidates and selected a single drug candidate to…
Akari Therapeutics Provides Update on Development of Long-Acting PAS-Nomacopan for Treatment of Geographic Atrophy
Akari has completed evaluation of long-acting PAS-nomacopan candidates and selected a single drug candidate to…
INmune Bio Inc. Announces Novel MRI Biomarker Data Demonstrating Improvement in Gray Matter in Patients with Alzheimer’s Disease
Analysis of MRI scans in participants from an open label Phase 1b study demonstrates that CDM®, a novel gray matter biomarker, is improved following three months…
INmune Bio Inc. Announces Novel MRI Biomarker Data Demonstrating Improvement in Gray Matter in Patients with Alzheimer’s Disease
Analysis of MRI scans in participants from an open label Phase 1b study demonstrates that CDM®, a novel gray matter biomarker, is improved following three months…
PDS Biotech Strengthens Intellectual Property Portfolio Governing A Combination of Versamune® and PDS0301
Composition of matter and use patent for Versamune® in combination with PDS0301 allowed in Canada…
PDS Biotech Strengthens Intellectual Property Portfolio Governing A Combination of Versamune® and PDS0301
Composition of matter and use patent for Versamune® in combination with PDS0301 allowed in Canada…
APIE Therapeutics Appoints Ashwin Datt Chief Executive Officer
Former CEO and Founder, Esther Alegria Remains on Executive Team Focused on Driving Research &…
APIE Therapeutics Appoints Ashwin Datt Chief Executive Officer
Former CEO and Founder, Esther Alegria Remains on Executive Team Focused on Driving Research &…
Mendus publishes prospectus regarding previously announced rights issue and directed issue
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN…
Mendus publishes prospectus regarding previously announced rights issue and directed issue
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN…
electroCore Provides Select Second Quarter 2023 Financial Guidance
Record revenue of approximately $3,550,000 for the three months ended June 30, 2023; 65% increase…
electroCore Provides Select Second Quarter 2023 Financial Guidance
Record revenue of approximately $3,550,000 for the three months ended June 30, 2023; 65% increase…
TRACON Pharmaceuticals Announces Collection of Arbitration Award from I-Mab Biopharma
Collection of Award Extends Cash Runway into early 2024 and Past Expected Full Accrual of…
TRACON Pharmaceuticals Announces Collection of Arbitration Award from I-Mab Biopharma
Collection of Award Extends Cash Runway into early 2024 and Past Expected Full Accrual of…
Recce Pharmaceuticals Announces First Cohort Dosed in RECCE® 327 Rapid Infusion Phase I/II Urinary Tract Infection (UTI) Clinical Trial
Highlights: First cohort in Phase I/II urinary tract infection (UTI) rapid infusion intravenous (IV) study…
Recce Pharmaceuticals Announces First Cohort Dosed in RECCE® 327 Rapid Infusion Phase I/II Urinary Tract Infection (UTI) Clinical Trial
Highlights: First cohort in Phase I/II urinary tract infection (UTI) rapid infusion intravenous (IV) study…
Longeveron Appoints Dr. Nataliya Agafonova as Chief Medical Officer
Experienced Pharma Industry Clinical Operations Leader to Spearhead Development of Cellular Therapy Programs MIAMI, July…